Table 1.

Association between JPH3 protein expression and clinicopathological parameters in 137 primary colorectal tumor cases

Clinicopathological parameters	n	JPH3 protein expression		P-value
		Low expression n=87 (63.5%)	High expression n=50 (36.5%)
Sex
Male	79	46 (58.2%)	33 (41.8%)
Female	58	41 (70.7%)	17 (29.3%)	0.134
Age
<63	70	46 (65.7%)	24 (34.3%)
≥63	67	41 (61.2%)	26 (38.8%)	0.583
Differentiation
Well Moderate	72 46	41 (56.9%) 31(67.4%)	31 (43.1%) 15 (32.6%)
Poor	19	15 (78.9%)	4 (21.1%)	0.166
pT categories
T1/T2	31	15 (48.4%)	16 (51.6%)
T3/T4	106	72 (67.9%)	34 (32.1%)	0.047
pN categories
pN0	69	36 (52.2%)	33 (47.8%)
pN1/2	68	51 (75%)	17 (25%)	0.006
pM categories
pM0	122	74 (60.7%)	48 (39.3%)
pM1	15	13 (86.7%)	2 (13.3%)	0.048
Duke stage
A/B	66	34 (51.5%)	32 (48.5%)
C/D	71	53 (74.6%)	18 (25.4%)	0.005